Quick Overview: Chair, Stephen V. Liu, MD, and Ibiayi Dagogo-Jack, MD, discuss Do you know the best strategies for genomic testing in Liza Villaruz, MD, University of Pittsburgh, Pittsburgh, PA, describes strategies to improve outcomes in metastatic non-small cell ...

Perfecting Precision In Nsclc Practice - Detailed Overview & Context

Chair, Stephen V. Liu, MD, and Ibiayi Dagogo-Jack, MD, discuss Do you know the best strategies for genomic testing in Liza Villaruz, MD, University of Pittsburgh, Pittsburgh, PA, describes strategies to improve outcomes in metastatic non-small cell ... Alexander Drilon, MD, and Benjamin Levy, MD, discuss Benjamin P. Levy, MD; Jonathan W. Riess, MD, MS; Lyudmila A. Bazhenova, MD; and Zofia Piotrowska, MD, explore strategies for ... This content has been developed for healthcare professionals only. Patients who seek health information should consult with their ...

In a recent interactive webinar, renowned experts Prof. Fernando López-Ríos, Assoc. Prof. Alicia Morgans and Assoc. Prof. Chair, Rebecca S. Heist MD, MPH, discusses Dara L. Aisner, MD, PhD, Joshua Bauml, MD, and Paul A. VanderLaan, MD, PhD, discuss targeted treatment and biomarker ... James Spicer, FCRP, PhD, MRCP, MBBS, King's College London, London, UK, outlines the discussion around tumor infiltrating ... Bruce Johnson, MD of the Dana-Farber Cancer Institute, Boston, MA has recently been elected as President of the American ... Dr. Jack West reviews data from ESMO 2017 & the NEJM paper on the PACIFIC trial of durvalumab vs. placebo as consolidation ...

Benjamin P. Levy, MD, and Rasheda Persinger, AGNP-C, discuss the integral role of advanced Advancing Care for Patients With EGFR Mutation–Positive Giorgio Vittorio Scagliotti, MD, PhD, from the University of Turin, Turin, Italy, discusses challenges in the use of personalized ...

Photo Gallery

Perfecting Precision in NSCLC Practice: Are You Optimally Integrating Biomarker-Driven Therapy?
Precision in Practice: Essential Strategies for Genomic Testing in NSCLC
Optimizing precision medicine in NSCLC
Improving Outcomes in Molecularly Altered NSCLC Through Precision Testing and Treatment
Best Practices in Molecular Profiling in NSCLC
Making Precision Decisions for Patients with EGFRm NSCLC
Highlights: Precision oncology in practice- testing through to treatment in lung and prostate cancer
Precision Medicine for Lung Cancer
Reinforcing Precision Tactics in Genomically Altered Resectable NSCLC
Precision oncology in practice – testing through to treatment in lung and prostate cancer
It’s Precisely the Time for More Precision in Genomic Testing and Targeted Treatment of NSCLC
Precision Decisions in Genomic Testing and Targeted Treatment of NSCLC
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored